Logout
Lundbeck sites
Contact Us
About Cipralex
Key Publications
Q & A
Prescribing Information
You are here:
Front page
»
About Cipralex
»
Indications
»
Efficacy in social anxiety disorder (SAD)
PRINT
TIP A COLLEAGUE
About Cipralex
Indications
Efficacy in major depressive disorder (MDD)
Efficacy in generalised anxiety disorder (GAD)
Efficacy in social anxiety disorder (SAD)
Efficacy in panic disorder (PD)
Efficacy in obsessive compulsive disorder (OCD)
Tolerability
Adverse events
Discontinuation symptoms
Overdose
Contraindications
Special warnings and precautions
Alcohol use
Pregnancy
Fast onset of action
Cipralex vs. venlafaxine XR
Cipralex vs. citalopram
How does it work?
Serotonin Dual-Action
Visualisations
Treatment with Cipralex
Efficacy in social anxiety disorder (SAD)
Cipralex vs. paroxetine
After 24 weeks of treatment, escitalopram (20 mg/day) showed superior efficacy to paroxetine (20 mg/day) in SAD.
Cipralex vs. placebo
In SAD, Cipralex showed superior efficacy over placebo on the Liebowitz Social Anxiety Scale (LSAS).
Clinical relevance of Cipralex compared with placebo was indicated by the improvement of work and social-life items of the Sheehan disability scale.
Published: 03/05/2006 Last updated: 02/01/2012
Key Publications
Superior efficacy in anxiety
Stein 2006
Lader 2004